PROPHASE LABS INC reports a Return on Equity (ROE) of -744.21%.

What is PRPH's dividend yield?

PROPHASE LABS INC offers a dividend yield of 0.00%.

What is PRPH's Deepscope Quality Score?

Deepscope rates PRPH's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy PRPH?

Deepscope's AI Timing Score for PRPH is 0 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does PRPH belong to?

PROPHASE LABS INC is classified under the Healthcare >> Diagnostics & Research sector on the NASDAQ exchange.

หุ้น PRPH (NASDAQ) | PROPHASE LABS INC – วิเคราะห์โดย Deepscope

Stock Check ข้อมูลอัปเดตรายวัน ที่เวลา 09.30 น.
(Price: 2026-06-01 | FS: 2026-03-31)

PRPH

PROPHASE LABS INC

US:NASDAQ STOCK Healthcare >> Diagnostics & Research News 94

USD 0.12

0.01 (6.06%) Day Change

Watchlist Portfolio Compare Chart

2.27

D/E

-744.2%

ROE

-43.6%

ROA

0.00%

Div Yield

PROPHASE LABS INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 0.12 Price 0.01 (6.06%) Day Change	NEWS SCORE: 94

PRPH มีคุณภาพโดยรวมไม่ดี ( คะแนนปัจจัยพื้นฐาน = 46) และ จังหวะเข้าซื้อ ...(ล็อกอินเพื่อดู)...

Loading chart...

46 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: อัตราผลตอบแทนผู้ถือหุ้น (ROE) ค่อนข้างต่ำ
อัตราผลตอบแทนสินทรัพย์ (ROA) ค่อนข้างต่ำ
อัตราผลตอบแทนผู้ถือหุ้น (ROE) ในอดีต ค่อนข้างต่ำ
อัตราผลตอบแทนผู้ถือหุ้น (ROE) ลดลงอย่างมีนัยยะสำคัญ
อัตราการเติบโตของอัตราผลตอบแทนสินทรัพย์(ROA) ปัจจุบันต่ำกว่าเกณฑ์
อัตรากำไรสุทธิ ค่อนข้างต่ำ
อัตรากำไรสุทธิในอดีต ค่อนข้างต่ำ

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

ถ้าดูอย่างละเอียดจะพบว่า ปัจจัยทางคุณภาพ ไม่ดี สุขภาพทางการเงิน ไม่ดี และ ประสิทธิภาพการทำกำไร ยังไม่ดีนัก , ...

ปัจจัยทางคุณภาพ

48%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	94
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	0.12
PBV / Sector	0.17 / -23.44 GREAT
Earning Per Share	-5.09

PE / Sector	N/A / 37.86
PEG or PE/Growth / Sector	N/A / 1.41
Average 1M Daily Value	3563.499065000000
Average 1W Daily Value	2744.888200000000

ปัจจัยทางเทคนิค

28%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

สุขภาพทางการเงิน

39%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ประสิทธิภาพการทำกำไร

56%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-705.98 / 12.69
NPM Average (%) / Sector	-371.26 / 7.99
NPM Change Average (%) / Sector	421.16 / -5.21 GREAT
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-43.61 / 11.23
ROA Average (%) / Sector	-29.97 / -82.28
ROA Change Average (%) / Sector	45.53 / 159.98 GREAT
ROE (%) / Sector	-744.21 / -86.57
ROE Average (%) / Sector	-379.04 / -2.21
ROE Change Average (%) / Sector	463.36 / -44.18 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

ผลตอบแทนต่อผู้ถือหุ้น

37%

Dividend (%) / Sector	N/A / 0.26
Dividend Average (%) / Sector	6.23 / 1.20 GREAT
Dividend Change Average (%) / Sector	N/A / 7.47

รายละเอียดการจดทะเบียน

Analyze Date	2026-06-06 09:09:07
Symbol	PRPH
Name	PROPHASE LABS INC
Sector	Healthcare >> Diagnostics & Research
Market	NASDAQ
Listed Shares	4.74 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	0.59 / 32,142.66

ข่าว, ประมาณการ, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 711 Stewart Avenue, Garden City, NY, United States, 11530

Phone: 215 345 0919

Website: https://www.prophaselabs.com

Employees: 96

Sector: Healthcare >> Diagnostics & Research

Description: ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of dietary supplements under the TK supplements, including Legendz XL, a male sexual enhancement; and Triple Edge XL, an energy and stamina booster. It also develops BE-Smart Esophageal Pre-Cancer diagnostics screening test for early detection of esophageal cancer; genomics testing technologies to analyze entire genomes, including the genes and chromosomes in deoxyribonucleic acid; DNA Expand, a platform that allows consumers to upload their DNA data from previous DNA tests obtained from other service providers; and LB-1 and LB-2 for the treatment of cancer, inflammatory diseases or symptoms and memory related syndromes, diseases or symptoms, including dementia and Alzheimer's disease. In addition, the company provides a broad range of COVID-19 related clinical diagnostic and testing services, comprising PCR testing for COVID-19, and Influenza A and B, as well as rapid antigen testing for COVID-19. It offers its genome sequencing products to consumers online with plans to sell in food, drug, and mass retail stores. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.